Distribution · GCC · Announced 30 Jul 2026
SPIMACO → Cigalah Gulf Medical
SPIMACO appointed Cigalah Gulf Medical as a distributor for its products in Qatar under a five-year agreement, renewable for two years, in a market where it has almost no registered presence today.
Parties: SPIMACO (Saudi Arabia) → Cigalah Gulf Medical (Cigalah Group) (Qatar)
- Deal type
- Distribution
- Value
- Undisclosed
- Territory
- Qatar
- Therapeutic area
- Multi-therapy
- Asset
- SPIMACO portfolio
- Announced
- 30 Jul 2026
Our analysis
Why this matters
On 30 July 2026, SPIMACO (Tadawul: 2070) disclosed agreements, signed on 29 July, appointing two subsidiaries of Saudi Arabia's Cigalah Group as distributors of its products: Cigalah Drug Store in the UAE and Cigalah Gulf Medical in Qatar. The Qatar agreement runs for five years from signing, renewable by mutual agreement for two more years. There is no fixed contract value; value depends on future orders, and SPIMACO stated no direct financial impact at signing.
The UAE appointment adds a channel alongside an existing distributor. Qatar is different. MENA registration data show no active SPIMACO registrations there, so this agreement is effectively a market-entry vehicle rather than an extra channel.
The full analysis is free to read with a work email on this page.
Source: SPIMACO Tadawul disclosure via Mubasher; Dawaa News; Souq Al Dawaa